NXL vs. BSGM, NRXS, QTI, STRR, NUWE, HSDT, NDRA, TIVC, VRAYQ, and VIVE
Should you be buying Nexalin Technology stock or one of its competitors? The main competitors of Nexalin Technology include BioSig Technologies (BSGM), NeurAxis (NRXS), QT Imaging (QTI), Star Equity (STRR), Nuwellis (NUWE), Helius Medical Technologies (HSDT), ENDRA Life Sciences (NDRA), Tivic Health Systems (TIVC), ViewRay (VRAYQ), and Viveve Medical (VIVE). These companies are all part of the "electromedical equipment" industry.
Nexalin Technology (NASDAQ:NXL) and BioSig Technologies (NASDAQ:BSGM) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, dividends, risk, earnings, community ranking, valuation and media sentiment.
Nexalin Technology has a beta of 5.8, meaning that its stock price is 480% more volatile than the S&P 500. Comparatively, BioSig Technologies has a beta of 0.7, meaning that its stock price is 30% less volatile than the S&P 500.
BioSig Technologies received 102 more outperform votes than Nexalin Technology when rated by MarketBeat users.
BioSig Technologies has a net margin of 0.00% compared to Nexalin Technology's net margin of -3,088.12%. Nexalin Technology's return on equity of -154.84% beat BioSig Technologies' return on equity.
In the previous week, BioSig Technologies had 1 more articles in the media than Nexalin Technology. MarketBeat recorded 3 mentions for BioSig Technologies and 2 mentions for Nexalin Technology. BioSig Technologies' average media sentiment score of 1.19 beat Nexalin Technology's score of 0.94 indicating that BioSig Technologies is being referred to more favorably in the news media.
Nexalin Technology has higher revenue and earnings than BioSig Technologies.
0.6% of Nexalin Technology shares are owned by institutional investors. Comparatively, 7.2% of BioSig Technologies shares are owned by institutional investors. 27.7% of Nexalin Technology shares are owned by insiders. Comparatively, 9.3% of BioSig Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
Nexalin Technology and BioSig Technologies tied by winning 6 of the 12 factors compared between the two stocks.
Get Nexalin Technology News Delivered to You Automatically
Sign up to receive the latest news and ratings for NXL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NXL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Nexalin Technology Competitors List
Related Companies and Tools
